Flashlight

DOI: 10.4244/EIJ-D-24-00795

Transcaval transcatheter aortic valve implantation via left-sided venous access

Conor J. Doyle, MB, BCh, BAO, MRCPI; Ivan P. Casserly, MB, BCh, BAO, FRCPI

We describe a technique to facilitate transcaval (TC) transcatheter aortic valve implantation (TAVI) in a patient with an occluded right common iliac vein. We highlight the feasibility of a left-sided femoral venous approach and the technique employed to overcome the technical challenge encountered in achieving successful transcaval access.

An 86-year-old male with severe symptomatic aortic stenosis and severe peripheral arterial disease presented for elective TC TAVI. Transcaval access was preferred over transaxillary access to minimise the risk of stroke in a patient with significant atherosclerotic disease, given that this access site avoids instrumenting the head and neck vessels. A conventional transcaval approach via right common femoral venous (CFV) access (Figure 1A) was precluded by occlusion of the patient’s right common iliac vein (CIV), presumed secondary to a prior undiagnosed deep vein thrombosis (Figure 1B). An attempt was then made to achieve TC access from the left CFV access site rather than exploring percutaneous revascularisation of the right iliac venous occlusion, as we anticipated this would be a more challenging procedure. However, due to the angulation between the...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 12
Jun 16, 2025
Volume 21 Number 12
View full issue


Key metrics

Suggested by Cory

Flashlight

10.4244/EIJ-D-24-00429 May 16, 2025
Transcaval access with an IVUS-assisted aorta-outward puncture
Muñoz Bravo J et al

EXPERT REVIEW

10.4244/EIJ-D-18-00552 Sep 7, 2018
Current state of alternative access for transcatheter aortic valve implantation
Lanz J et al
free

Clinical research

10.4244/EIJ-D-19-00797 Feb 7, 2020
Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registry
Costa G et al
free

10.4244/EIJV9SSA7 Sep 15, 2013
Subclavian TAVI: more than an alternative access route
Petronio AS et al
free

10.4244/EIJV15I15A237 Feb 7, 2020
Do we need alternative access in TAVR anymore?
Ben Ali W et al
free

Image – Interventional flashlight

10.4244/EIJ-D-21-00592 Mar 18, 2022
Cusp overlap technique during valve-in-valve TAVI using the novel Navitor transcatheter heart valve
Wong I et al
free

Short report

10.4244/EIJ-D-18-01192 Feb 7, 2020
Early outcomes of transcarotid access for transcatheter aortic valve implantation
Verhoye J et al
free
Trending articles
310.43

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
35

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved